SPINK1 and ovarian neoplasm: In our previous work with this patient cohort, we found a serine protease inhibitor (SPINK1) to be a prognostic factor for nonserous ovarian tumors; subsequent studies using cell culture models determined that SPINK1-driven ovarian cancer cell proliferation is mediated through EGFR signaling pathways [45].